With the fourth revolution heralding large-scale digital connectivity across artificial intelligence learning systems and networks, the ability to connect digitally and transfer data across complex networks is fundamentally important to the pharmaceutical industry. The complexity of data transactions and requirements, particularly in the supply chain, is immense. The development, production, and transfer of drugs and therapeutic treatments rely on a complex supply chain, involving multiple interactions and partnerships, to ensure that therapeutic products are supplied, manufactured, and distributed safely, efficiently, and effectively.
Biomanufacturers already use electronic data to analyze and improve elements of their processes. However, for a more complete understanding of the process, electronic data needs to be exchanged through the entire supply chain. The Team have produced a video here to highlight the importance.
Improving real-time data exchange can benefit the inbound supply chain in many ways, from improving accuracy, reducing costs, and maximizing safety, reliability, and efficiency to speeding up drug production, ensuring supply and simplifying processes.
BioPhorum is working with the biomanufacturing and supplier community to progress the adoption of electronic data exchange (EDE) to enable these improvements and deliver an efficient, and effective drug production and global supply. The BioPhorum EDE workstream set out to establish the baseline for EDE across participating members, to understand:
- How suppliers and biomanufacturers were working with EDE for raw materials across their inbound supply chain
- Whether they were using the ASTM standard and, if so, its application and value to their company
- Insights for improving EDE across the sector.
Survey results cover utilization, prioritization, ASTM E3077-17 standard utilization and the benefits and challenges in implementing it, EDE maturity, benefits and challenges for EDE in the inbound supply chain, EDE accelerator and other conclusions.